Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.047 | 0.7 |
mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.057 | 0.7 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |